Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunoglobulin replacement therapy by slow subcutaneous infusion.

× No keyword cloud information.

25 in total

1. A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies.

Authors: Melvin Berger
Journal: Curr Allergy Asthma Rep Date: 2002-09 Impact factor: 4.806

2. Immune globulin subcutaneous (human), 20% liquid.

Authors:
Journal: P T Date: 2010-08

3. Home intravenous immunoglobulin therapy by self-administration.

Authors: E R Ashida; A Saxon
Journal: J Clin Immunol Date: 1986-07 Impact factor: 8.317

4. Immune globulin subcutaneous (human) vivaglobin: for the treatment of primary immunodeficiency diseases.

Authors:
Journal: P T Date: 2009-06

5. An immune globulin intravenous (human), 10% liquid privigen: for the treatment of primary immunodeficiency diseases.

Authors:
Journal: P T Date: 2009-06

6. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy.

Authors: H M Chapel; G P Spickett; D Ericson; W Engl; M M Eibl; J Bjorkander
Journal: J Clin Immunol Date: 2000-03 Impact factor: 8.317

7. Intravenous IgG: A New Therapeutic Tool.

Authors: L K Boshkov; J G Kelton
Journal: Can Fam Physician Date: 1988-11 Impact factor: 3.275

Review 8. Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis.

Authors: Hassan Abolhassani; Mohammad Salehi Sadaghiani; Asghar Aghamohammadi; Hans D Ochs; Nima Rezaei
Journal: J Clin Immunol Date: 2012-06-23 Impact factor: 8.317

9. Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease.

Authors: Suzanne Skoda-Smith; Troy R Torgerson; Hans D Ochs
Journal: Ther Clin Risk Manag Date: 2010-02-02 Impact factor: 2.423

10. Subcutaneous immunoglobulin-g replacement therapy with preparations currently available in the United States for intravenous or intramuscular use: reasons and regimens.

Authors: Akhilesh Chouksey; Kimberly Duff; Nancy Wasserbauer; Melvin Berger
Journal: Allergy Asthma Clin Immunol Date: 2005-09-15 Impact factor: 3.406